press articles|articoli stampa

  

  
31 - 40 of 66 Results

  1. Aspartaam weer onder vuur   View Pdf d
    Geplaatst, June 19, 2007

  2. Bentivoglio festeggia l'Istituto Ramazzini   View Pdf d
    Il Resto del Carlino, June 01, 2007

  3. Prevenire e curare i tumori alla nuova clinica Ramazzini   View Pdf d
    Corriere della Sera, May 11, 2007

  4. Governo al nostro fianco nella ricerca   View Pdf d
    Il Resto del Carlino, May 11, 2007

  5. Aspartame's safety questioned again   View Pdf d
    CBS News Early Show, April 24, 2007

  6. Aspartame: Is BLUE...bad for you?   View Pdf d
    The Empowered Doctor WPIX Channel 11 New York, April 23, 2007

  7. L'aspartame รจ cancerogeno, anche usato in piccole dosi   View Pdf d
    Il Resto del Carlino, April 13, 2007

  8. Il Gioiello Ramazzini Avamposto della Scienza   View Pdf d
    Il Resto del Carlino, March 15, 2007

  9. Ramazzini Set to Publish New Aspartame Study   View Pdf d
    EU Food Law, March 09, 2007

  10. Fiorella Belpoggi, MD: Per Aspera Ad Astra   View Pdf d
    JECH, November 26, 2006

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7   Prev Next

November 15, 2008
EHP commentary argues the limits of 2-year bioassay exposure regimens: Ramazzini lifespan studies aspartame and toluene cited.
In a recent commentary entitled "The limits of 2-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens"Environ Health Perspect 116:11, 2008, authors James Huff, Devra Davis and Michael Jacobson argue that the sensitivity of chemical carcinogenesis bioassays would be enhanced by exposing rodents beginning in utero and continuing for 30 months (130 weeks) or until their natural deaths at up to about 3 years. Citing lifespan studies conducted by the European Ramazzini Foundation on aspartame and toluene the authors conclude that observing rodents until their natural deaths (i.e the Ramazzini lifespan model) increases the sensitivity of bioassays, avoids false-negative results, and strengthens the value and validity of results for regulatory agencies.
archive/archivio